Impact of Aspirin on Timing of Birth in Pregnancies With Clinical Manifestations of Placental Dysfunction: Evidence From a Multicentre Randomised Clinical Trial
BJOG: An International Journal of Obstetrics & Gynaecology · 2025
DOI: 10.1111/1471-0528.18211 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025. Verfasst von Ioannis Papastefanou und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London,…. Hauptthemen laut MEDLINE: Aspirin, Placenta Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Astraia GmbH, the Faculty of Medicine, the Chinese University of Hong Kong, Thermo Fisher Scientific.
Abstract (Originalsprache)
Objective
To examine whether aspirin delays gestational age at delivery (GAD) in pregnancies with placental dysfunction (PD) phenotypes (preeclampsia [PE], small‐for‐gestational‐age [SGA], placental abruption and/or stillbirth).
Design
A secondary analysis of a multicentre stepped‐wedge cluster randomised trial.
Setting
18 maternity/diagnostic units in Asia. Population Singleton pregnancies examined at 11–13 +6 weeks.
Methods
A model in which the effect of aspirin is to delay the GAD in pregnancies with PD was developed. Main Outcome Measures GAD in pregnancies with PD.
Results
Aspirin administration was associated with a significant reduction in PD < 32 weeks (adjusted relative risk 0.543, 95% CI: 0.330–0.864), with a trend for an increase of PD ≥ 32 weeks (test for trend, p ‐value = 0.0018). Similar findings were observed individually for PE, SGA and/or placental abruption. At 24 weeks, the aspirin‐induced prolongation of pregnancies with PD was 2.85 weeks (95% CI: 0.44–5.40), and this effect was decreased by −0.19 weeks (95% CI: −0.33 to −0.05) for each week of gestation; therefore, at 28 and 32 weeks' gestation, the aspirin‐induced prolongation was 2.09 and 1.33 weeks, respectively.
Conclusions
In this secondary analysis of a cluster randomised trial, women at high risk of PE who are destined to develop a clinical spectrum of PD may benefit from longer pregnancy duration through aspirin administration in early pregnancy. Aspirin may delay the GAD due to PD, particularly benefiting those deliveries that would occur at earlier gestations without aspirin administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
- Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China.
- Fetal Medicine Centre, Tam Anh HCMC General Hospital, Ho Chi Minh City, Vietnam.
- Hanoi Obstetrics and Gynecology Hospital, Hanoi, Vietnam.
- CRIFM Prenatal Medical Clinic, Osaka, Japan.
- Toyama University Hospital, Toyama, Japan.
ORCID-Profile: Ioannis Papastefanou, Yunyu Chen, Yali Hu, Daljit S Sahota
Förderung
- Astraia GmbH
- the Faculty of Medicine, the Chinese University of Hong Kong
- Thermo Fisher Scientific
- Revvity Inc
- Roche Diagnostics
- GE Healthcare
Zitieren
APA
Papastefanou, I., Chen, Y., Nguyen-Hoang, L., Nguyen, D. A., Dinh, L. T., Pooh, R. K., Shiozaki, A., Zheng, M., Hu, Y., Wu, Y., Kusuma, A., Yapan, P., Choolani, M. A., Kaneko, M., Luewan, S., Chang, T. Y., Chaiyasit, N., Nanthakomon, T., Jiang, Y., …, & Poon, L. C. (2025). Impact of Aspirin on Timing of Birth in Pregnancies With Clinical Manifestations of Placental Dysfunction: Evidence From a Multicentre Randomised Clinical Trial. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18211
Vancouver
Papastefanou I, Chen Y, Nguyen-Hoang L, Nguyen DA, Dinh LT, Pooh RK, et al. Impact of Aspirin on Timing of Birth in Pregnancies With Clinical Manifestations of Placental Dysfunction: Evidence From a Multicentre Randomised Clinical Trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.18211
BibTeX
@article{Papastefanou2025,
author = {Papastefanou, Ioannis and Chen, Yunyu and Nguyen-Hoang, Long and Nguyen, Duy-Anh and Dinh, Linh Thuy and Pooh, Ritsuko K and Shiozaki, Arihiro and Zheng, Mingming and Hu, Yali and Wu, Yunping and Kusuma, Aditya and Yapan, Piengbulan and Choolani, Mahesh A and Kaneko, Mayumi and Luewan, Suchaya and Chang, Tung-Yao and Chaiyasit, Noppadol and Nanthakomon, Tongta and Jiang, Yanmin and Shaw, Steven W and Leung, Wing Cheong and Mohamad, Ainaa Syazana and Aguilar, Angela and Lau, So Ling and Lee, Nikki M W and Tang, Esther Wai Chi and Sahota, Daljit S and Chong, Marc K C and Poon, Liona C},
title = {Impact of Aspirin on Timing of Birth in Pregnancies With Clinical Manifestations of Placental Dysfunction: Evidence From a Multicentre Randomised Clinical Trial},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
doi = {10.1111/1471-0528.18211}
}
EUVIMED